Biomm S.A

SA:BIOM3 Brazil Biotechnology
Market Cap
$156.17 Million
R$951.05 Million BRL
Market Cap Rank
#18204 Global
#156 in Brazil
Share Price
R$6.95
Change (1 day)
-2.80%
52-Week Range
R$5.90 - R$10.64
All Time High
R$23.65
About

Biomm S.A. operates as a biotechnology company in Brazil. The company offers insulin products for the treatment of diabetes, including AFREZZA, a Human insulin powder for inhalation; GLARGILIN, a glargine insulin; WOSULIN N and WOSULIN R; and Lifepen G, a reusable insulin injection pen. It also provides Bevyx for the treatment of metastatic colorectal cancer; HERZUMA for the treatment of early-st… Read more

Biomm S.A (BIOM3) - Total Liabilities

Latest total liabilities as of September 2025: R$200.93 Million BRL

Based on the latest financial reports, Biomm S.A (BIOM3) has total liabilities worth R$200.93 Million BRL as of September 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Biomm S.A - Total Liabilities Trend (2004–2024)

This chart illustrates how Biomm S.A's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

Biomm S.A Competitors by Total Liabilities

The table below lists competitors of Biomm S.A ranked by their total liabilities.

Company Country Total Liabilities
ABOV Semiconductor Co. Ltd
KQ:102120
Korea ₩132.48 Billion
ThinTech Materials Technology Co Ltd
TWO:3663
Taiwan NT$1.83 Billion
Viking Tech
TWO:3624
Taiwan NT$610.11 Million
Ashiana Housing Limited
NSE:ASHIANA
India ₹32.50 Billion
Huayang Intelligent Co Ltd
SHE:301502
China CN¥237.04 Million
Paysign Inc
NASDAQ:PAYS
USA $163.75 Million
Sula Vineyards Limited
NSE:SULA
India ₹5.27 Billion

Liability Composition Analysis (2004–2024)

This chart breaks down Biomm S.A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.45 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio 0.11 Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.71 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.41 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Biomm S.A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Biomm S.A (2004–2024)

The table below shows the annual total liabilities of Biomm S.A from 2004 to 2024.

Year Total Liabilities Change
2024-12-31 R$202.88 Million -8.52%
2023-12-31 R$221.76 Million -9.85%
2022-12-31 R$245.98 Million -4.75%
2021-12-31 R$258.25 Million +6.06%
2020-12-31 R$243.49 Million +3.52%
2019-12-31 R$235.21 Million +17.85%
2018-12-31 R$199.59 Million -1.72%
2017-12-31 R$203.09 Million +18.45%
2016-12-31 R$171.46 Million +49.68%
2015-12-31 R$114.55 Million +58.07%
2014-12-31 R$72.46 Million +148.65%
2013-12-31 R$29.14 Million +0.48%
2012-12-31 R$29.00 Million +44.59%
2011-12-31 R$20.06 Million +123.68%
2010-12-31 R$8.97 Million -15.96%
2009-12-31 R$10.67 Million -56.24%
2008-12-31 R$24.39 Million +104.31%
2007-12-31 R$11.94 Million +47.94%
2006-12-31 R$8.07 Million -36.13%
2005-12-31 R$12.63 Million +137.98%
2004-12-31 R$5.31 Million --